Work

PI3-kinase inhibition: a target for drug development?

Year: 2000

Type: review

Source: Molecular Medicine Today

DOI: 10.1016/s1357-4310(00)01770-6

Authors: Robert C. Stein, Michael D. Waterfield

Institutions: The Royal Free Hospital, Ludwig Cancer Research, University College London

Language: English

Topic: PI3K/AKT/mTOR signaling in cancer

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2063817360

FWCI: 1.481

Cites: 60

Cited by: 191

Related to: 10